AASLD: American Association for the Study of Liver Diseases
Home | Contact Us | Log In/Out
About Us | Join | Public PolicyPatients | Giving to AASLD | Career Center | News | Worksites | Related Societies
The Best of The Liver Meeting® 

The Best of The Liver Meeting® 2010 
|

The Best of The Liver Meeting® lets you catch up with what you missed at the meeting and enables you to revisit a session.  All of the sessions are presented with audio and synchronized slide presentations.  Below is a list of The Best of The Liver Meeting® 2010 sessions.

 Program Presentation  Presenter
Postgraduate Course

View Postgraduate Course Session Presentations

 

Hans Popper Basic Science State-of-the-Art Lecture Johan Auwerx, MD, PhD
Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture

Hepatobiliary Neoplasia -- Is Transplantation the Answer?

 

 
Michael M. Abecassis, MD
Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture

The Good, the Bad, and the Ugly: Innate Immunity in Liver Injury

 


Gyongyi Szabo, MD, PhD
Leon Schiff State-of-the-Art Lecture David Goldstein, PhD
Hepatitis Debrief HCV Debrief


Paul J. Pockros, MD
General Hepatology Update

Infectious Complications of Cirrhosis

 

Guadalupe Garcia-Tsao, MD

Iron Overload

 

Kyle Brown, MD

Vitamin D and Statins

 

Naga P. Chalasani, MD
Emerging Trends in Imaging Liver Disease

Imaging of Masses in Non-Cirrhotic Liver 

Claude B. Sirlin, MD

Imaging of Masses in Cirrhotic Liver

 

Bachir Taouli, MD

Imaging to Assess Progression of Chronic Liver Disease

 

Scott Reeder, MD, PhD
Measuring HPVG Correctly Juan Carlos Garcia-Pagan, MD
Global Forum Understanding the Global Burden of Liver Disease
Steven Wiersma, MD
North American Perspective

Hashem B. El-Serag, MD
European Perspective

Mark R. Thursz
Latin American Perspective

Martin  Padilla, MD
Asian Perspective

Shiv K. Sarin, MD
African Perspective

Ayman Yosry, MD
Advances for Practitioners Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype I Infection

Donald M. Jensen, MD
Genetic Variation in IL28B Predicts Hepatitis C Treatment-induced Viral Clearance
Gary L. Davis, MD

Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey

Marc G. Ghany, MD